510(k) K261530
K261530 is an FDA 510(k) premarket notification submitted by Deka Research and Development for the device "iiSure Infusion Set". The FDA issued a decision of Substantially Equivalent on June 3, 2026. The device falls under product code FPA (Set, Administration, Intravascular), a Class II device regulated under 21 CFR 880.5440. Deka Research and Development has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- June 3, 2026
- Date Received
- May 8, 2026
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Set, Administration, Intravascular
- Device Class
- Class II
- Regulation Number
- 880.5440
- Review Panel
- HO
- Submission Type